Jennifer Wilkie is a partner in Gowlings' Ottawa office, an active member of the Firm’s intellectual property department and vice chair of the Firm’s Life Sciences Industry Group.
Jennifer has over 15 years experience in the intellectual property field and she has been a registered patent agent since 2000. Her practice has been primarily in patents, especially patent litigation and patent prosecution, with emphasis on pharmaceutical litigation and chemicals. Jennifer acts regularly for clients on patent infringement and patent impeachment matters, as well as judicial review proceedings, including applications under the Patented Medicines (Notice of Compliance) Regulations. She has appeared in the Federal Court and Federal Court of Appeal, as well as the Ontario Courts.
Her practice also involves providing strategic advice to clients on achieving optimal patent protection and enforcement. In the pharmaceutical context, this includes advice on patent portfolio management, patent listing, innovative drug listing, life cycle management and regulatory requirements under the Food and Drugs Act and Regulations.
Jennifer is a regular writer on intellectual property issues, in particular pharmaceutical patent issues. She is also the executive editor of Gowlings Pharmacapsules Newsletter.